What's Happening?
The U.S. Department of Health and Human Services (HHS) has announced a $144 million initiative to investigate the impact of microplastics on human health. The program, named Systematic Targeting Of MicroPlastics (STOMP), is spearheaded by the Advanced
Research Projects Agency for Health (ARPA-H). The initiative aims to measure microplastic exposure in humans, identify sources of risk, and develop solutions to mitigate these risks. Microplastics, which are nearly invisible, have been found in human lungs, arterial plaques, and brains, raising concerns about their potential to cause disease. The program will focus on developing affordable and accessible tools to measure and understand the distribution and effects of microplastics in the body.
Why It's Important?
This initiative is significant as it addresses the growing concern over microplastics, which are pervasive in the environment and have been linked to health issues. By understanding how microplastics affect human health, the program could lead to new regulations and interventions to protect public health. The research could also influence industries that rely on plastics, prompting them to seek safer alternatives. The findings may lead to policy changes and increased public awareness about the risks associated with microplastics, potentially driving demand for more sustainable products.
What's Next?
The STOMP program will proceed in phases, initially focusing on measurement and understanding the mechanisms of microplastic impact on health. The second phase will explore methods for removing microplastics from the body. The Centers for Disease Control and Prevention (CDC) will validate the methods developed, which could lead to new standards for assessing and mitigating microplastic exposure. The outcomes of this research may prompt further studies and collaborations aimed at reducing microplastic pollution and its health impacts.
